Guide for patients & caregivers
Positive Anti-Mitochondrial Antibody (AMA): What Does It Mean?
Positive anti-mitochondrial antibody (AMA)? Learn the link with primary biliary cholangitis, why ALP matters, what normal liver tests mean and what to ask.
Prepared with AI assistance and checked against the cited sources. No independent clinician review has been completed. How we prepare articles
What does a positive anti-mitochondrial antibody (AMA) mean?
A positive anti-mitochondrial antibody (AMA) test means the laboratory found antibodies that react with parts of mitochondria, the energy-producing structures inside cells. AMA is the antibody most closely linked with primary biliary cholangitis (PBC), a long-term condition in which the small bile ducts inside the liver become inflamed and damaged. On its own, though, the antibody result does not confirm PBC; it is interpreted alongside liver blood tests, especially alkaline phosphatase (ALP).
NIDDK reports that AMA is found in the blood of about 95% of people with PBC. The reverse is not automatically true: some people have AMA without the liver test pattern of PBC, and a weak positive can occur in other situations. This guide explains how clinicians usually connect the pieces and what to clarify at follow-up.
Symptoms that need urgent care
A positive AMA by itself is not an emergency. Seek urgent medical advice if the skin or the whites of the eyes turn yellow (jaundice), especially with dark urine, pale stools or itching. The NHS advises asking for an urgent GP appointment or using NHS 111 for jaundice; elsewhere, use your local urgent service.
Get emergency help for vomiting blood, black or tarry stools, new confusion or marked drowsiness, or rapidly increasing swelling of the abdomen. NIDDK lists bleeding from enlarged veins, fluid in the abdomen and confusion from toxin build-up among the complications of advanced liver disease. These symptoms take priority over waiting for a routine antibody review.
How is AMA linked with primary biliary cholangitis?
In PBC, the immune system attacks the small bile ducts. Bile then builds up in the liver and, over many years, can cause scarring. NIDDK describes PBC as more common in women and in middle age, with an average age at diagnosis of 60. The NHS notes that the rate of progression varies widely and can take decades, and that treatment can help slow liver damage.
Many people have no symptoms when PBC is found. NIDDK states that about 60% of people are diagnosed before symptoms begin, usually after a routine blood test. When symptoms occur, the most common are tiredness and itchy skin. Others include dry eyes and mouth, joint aches and discomfort in the upper right side of the abdomen. PBC can also occur alongside other autoimmune conditions, such as autoimmune thyroid disease and Sjögren's syndrome.
Why do ALP and other liver tests matter so much?
Alkaline phosphatase (ALP) is an enzyme that rises when bile flow is blocked or bile ducts are damaged, which is called a cholestatic pattern. NIDDK states that a doctor may diagnose PBC when AMA is present together with a higher-than-normal ALP, even without other signs or symptoms. The British Society of Gastroenterology (BSG) guideline says PBC should be considered whenever ALP, and sometimes GGT, is repeatedly raised without another explanation, and that a clinically significant AMA is then usually enough to confirm the diagnosis without a biopsy.
ALP can also come from bone, so the source is sometimes checked with GGT or other tests. The BSG guideline describes PBC as a sustained ALP rise above the upper limit of normal for more than six months. Reference ranges differ between laboratories, so compare each value with the range printed on your own report.
Once PBC is diagnosed, the NHS says an ultrasound scan is also needed to help rule out other bile duct problems, such as gallstones or narrowing, and to assess the liver. A liver biopsy is only occasionally recommended.
What if AMA is positive but liver tests are normal?
This is a common reason people search for answers. The BSG guideline states that the clinical significance of AMA with normal liver biochemistry is currently unclear. It notes that AMA with normal liver tests is seen in roughly 0.5% of the population, and that it is not known how much of this reflects more sensitive modern assays, false positives linked with other inflammatory conditions, or a true early stage of PBC.
Older studies followed people with AMA and normal liver tests seen in specialist clinics and found that most later developed typical PBC blood test changes. However, the guideline notes that over 18 years of follow-up none in that group developed cirrhosis, needed a transplant or died of PBC, and that the findings may not apply to everyone with a positive AMA.
The guideline recommends that people with AMA and normal liver tests have their liver blood tests checked every year, and are then managed as for classical PBC if an abnormality appears. This follow-up can often happen in primary care unless other factors, such as a related autoimmune condition, call for specialist review.
Can AMA be falsely positive or low titre?
Yes. The BSG guideline warns that a low-titre AMA can be a false positive in some inflammatory conditions, particularly fatty liver disease, where small ALP rises are also common. In that situation, clinicians may need more information to decide which liver problem is the main one.
The guideline also states there is no good evidence that a higher AMA level predicts a worse course once it is above the diagnostic threshold. About 5% of people with PBC are AMA negative, and some of them have other PBC-specific antinuclear antibodies instead. A small number of people with autoimmune hepatitis are AMA positive; their tests usually show a different pattern, with raised ALT, AST and IgG rather than a mainly raised ALP.
Questions to ask your clinician
Bring the antibody report and all recent liver panels, with dates and reference ranges. These questions can help focus the appointment:
- Was my AMA result strongly or weakly positive, and which method did the laboratory use?
- Is my ALP raised now, has it been raised for months, and does GGT suggest it comes from the liver?
- Do my results fit PBC, another liver condition, or neither for now?
- If my liver tests are normal, who will repeat them, how often, and what change would prompt a referral?
- Do I need an ultrasound, and would a biopsy add anything in my case?
- Should I be checked for related conditions, such as thyroid problems?
How comparing similar cases on SameCase can help
On SameCase, patients and verified doctors share de-identified cases. Reading how others with a positive AMA and normal or raised ALP described their test timelines can help you notice what to record and which questions to bring. Every case is different, so similar cases cannot diagnose you or predict your course. Your own clinician interprets your results.
Keep the follow-up plan clear
Before leaving the appointment, confirm what the AMA result means for you now, when liver tests will be repeated, and how results will reach you. Do not start, stop or change any medicine or supplement without talking to the prescriber. Seek urgent care for jaundice or the warning signs above, whatever the follow-up date.
Sources and further reading
- NIDDK: Diagnosis of primary biliary cholangitis (reviewed March 2021)
- NIDDK: Symptoms and causes of primary biliary cholangitis (reviewed March 2021)
- NIDDK: Definition and facts of primary biliary cholangitis (reviewed March 2021)
- NHS: Primary biliary cholangitis overview (reviewed February 2024)
- NHS: Symptoms of primary biliary cholangitis (reviewed February 2024)
- British Society of Gastroenterology/UK-PBC: Treatment and management of primary biliary cholangitis guideline (Gut 2018, CC BY 4.0, PMC)
- NHS: Jaundice and urgent advice (reviewed January 2024)
For patients & caregivers
Share your case and learn from others
Learn from doctors and other people's cases to find a way forward with your health problem. New cases are public immediately. Don't add names or identifying details.